Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00574626 · ClinicalTrials.gov registry record · NA
Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT00574626 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 51 participants.
The verdict
NCT00574626, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the difference in relapse rates and long term event free survival in patients with intermediate grade or immunoblastic non-Hodgkin's lymphoma (NHL) whose marrow is not obviously involved with NHL who are randomized to receive either an autologous bone marrow (ABMT) or peripheral stem cell transplant (PSCT). All patients with intermediate grade NHL with histologic negative bone marrow who would otherwise meet all eligibility criteria for high-dose therapy and ABMT are eligible for this study. Patients who are eligible will be randomized to either PSCT or ABMT at the time of enrollment into our transplant program.
Interventions
- PROCEDURE PBSCT
- PROCEDURE Bone Marrow Transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 1991-12-12 |
| Est. Completion | 2010-05-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00574626
The ClinicalTrials.gov registry entry for NCT00574626 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PBSCT is the first listed.
NCT00574626 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00574626 about?
NCT00574626 is a clinical study titled "Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma". The purpose of this study is to evaluate the difference in relapse rates and long term event free survival in patients with intermediate grade or immunoblastic non-Hodgkin's lymphoma (NHL) whose marrow is not obviously involved with NHL who are randomized to receive either an autologous bone marrow ...
What is the current status of trial NCT00574626?
This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 1991-12-12. Estimated completion is 2010-05-05.
What interventions are being tested in trial NCT00574626?
The interventions under investigation include: PBSCT (PROCEDURE), Bone Marrow Transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00574626?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.